Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 01 Jul 2024 13:11:58 +0200Thu, 27 Jun 2024 15:41:00 +0200Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/uzpruvoHuman medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/uzpruvoThu, 27 Jun 2024 15:41:00 +0200Human medicineUzpruvo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6101_en.pdfUzpruvo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6101_en.pdfThu, 27 Jun 2024 12:05:00 +0200Human medicine